A Clinical study to Evaluate the effectiveness of Reginald men Apollo Facewash for skin brightening and hydration

Btm Ventures Private Limited1 个研究点分布在 1 个国家目标入组 36 人开始时间: 2025年9月18日

试验速览

A single blind one arm study.

Each participant entering the trial will be assigned to a regimen of investigational product with the below assessments.

- Skin Gloss by Glossymeter (T0, T30min, T14Days, T28days)

- Skin Colour by Chromameter (T0, T14Days, T28days)

- Skin Pigmentation by Mexameter (T0 , T14days, T28 days)

- Skin Hydration with Corneometer (T0, T30min,T14days,T28days)

- TEWL for moisture barrier (T0, T30min,T14days,T28days)

- Dermat evaluation on a 5 point ordinal scale would be used for the blemishes (T0,T14and T28)

- Dermat evaluation on a 5 point ordinal scale would be used for the pore cleanliness post dermascope (T0, T14, T28)

- HD Imaging with DSLR or Visioscan (T0 and T28)

- Dermascopy Images ( T0 and T28day)

- Subject’s Self Assessments. (T28 only)

Male and Female with age 18-45 (80:20), Volunteers-36

Assessment Time: T0min, T+30 mins, T+14days, T+28 days

•Gender: Male and Female with age 18-45 (80:20) 2) Subjects with mild blemishes and dull skin.
•Subjects willing to give written informed consent 4) Women of child bearing potential must have a negative urine pregnancy test prior to study entry.
•Are free of any systemic or dermatologic disorder, which, in the opinion of the investigator, will interfere with the study results or increase the risk of adverse events.
•Are willing to avoid prolonged exposure of the treatment area to ultraviolet radiation (natural or artificial) for the duration of the study.

•1.Have any evidence of systemic cancer, squamous cell carcinoma, basal cell carcinoma, in the last 5 years, or any other confounding skin condition.
•2.Have open sores or open lesions in the treatment area(s).
•3.Have any condition that, in the opinion of the investigator, would confound the safety and/or efficacy assessments of the product.
•4.Have participated in any interventional clinical trial in the previous 90 days.
•5.Have a known sensitivity to any of the constituents of the test product including sensitivities.
•Have used, are using, or are planning to use immunosuppressive or immunomodulatory medication (i.e., biologics), including corticosteroids.
•Have not skin related issues.